The board of directors of Julphar Gulf Pharmaceutical Industries has decided to appoint  chief financial officer Jerome Carle as acting general manager.

 

The appointment will be effective following the departure of current chief executive officer Dr Ayman Sahli on April 20 and until a new CEO is appointed, said a statement.

 

His Highness Sheikh Faisal Bin Saqr Al Qassimi, Chairman of Julphar, said: “The board believes that Jerome is the right person to drive Julphar while we are looking for a new and highly qualified candidate to fill the CEO role, and we are grateful for Jerome’s readiness to endorse the role at this time. I want to thank Dr Ayman Sahli for his outstanding service to the company the past eight years, and I personally wish him well in the future."

 

Carle commented: “I would like to thank the Board of Directors for their trust. I am looking forward to working under their guidance. Together with the executive team, I am confident that we will prepare a smooth transition until our new CEO is appointed and ensure that Julphar is in the right direction to reach our 2020 vision.”

 

Established in 1980, Julphar is the largest generic pharmaceutical manufacturer in Middle East and North Africa, producing over 200 branded products across its 15 manufacturing facilities. – TradeArabia News Service